The overall goal of the candidate's research program is to define the genetic and non-genetic factors that determine the variability in human vascular response, both between individuals, and between ethnic groups. The investigator has previously shown marked interethnic differences in vascular response with attenuated beta-adrenergic and nitric oxide-mediated vasodilation and increased alpha-adrenergic vasoconstriction in African-Americans. Three related but separate projects are currently underway that extend these observations: 1) Ethnic differences in autonomic cardiovascular control comprises a series of studies designed to define and localize the mechanisms, including the relationship between psychological traits and sympathetic activity, which regulate vascular response in different ethnic groups. 2)""""""""Modulation of adrenergic response by estrogen"""""""" comprises a series of studies designed to probe central and peripheral components of adrenergic control in a targeted fashion to define the level(s) at which estrogen produces effects and to compare responses in African-American and Caucasian women. The effects of estrogen on basal sympathetic activity, stimulated sympathetic activity, central sympathoinhibition, presynaptic sympathetic regulatory mechanisms, postsynaptic vascular responsiveness and the effects on salt sensitivity will be all determined. 3) """"""""Genetic variability and vascular response"""""""" a project described in detail in this proposal has the overall aim of defining the role of genetic factors in the determination of vascular response through the study of individuals selected on the basis of genotype. We will examine the hypothesis that functionally significant polymorphisms of beta2-adrenoceptor, alpha1-adrenoceptor and endothelial nitric oxide synthase genes alter vascular response in humans. Thus, the present proposal embraces three concurrent, conceptually linked, projects that define genetic and non-genetic factors regulating human vascular response and will allow the investigator to continue to pursue a highly productive, patient oriented research career and focus on the long-term goal of understanding the mechanisms that regulate vascular response and how these differ between ethnic groups, both in health and disease. The unique research environment, the established ongoing research program and the investigator's commitment to mentoring will allow him to continue to contribute to the fostering of clinical research through the training of young clinical investigators.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
5K24HL004012-03
Application #
6388529
Study Section
Special Emphasis Panel (ZHL1-CSR-F (F1))
Program Officer
Schucker, Beth
Project Start
1999-06-01
Project End
2004-05-31
Budget Start
2001-06-01
Budget End
2002-05-31
Support Year
3
Fiscal Year
2001
Total Cost
$81,528
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Li, Chun; Schwarz, Ute I; Ritchie, Marylyn D et al. (2009) Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy. Blood 113:3925-30
Solus, Joseph; Chung, Cecilia P; Oeser, Annette et al. (2008) Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum 58:2662-9
Kurnik, Daniel; Li, Chun; Sofowora, Gbenga G et al. (2008) Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade. Pharmacogenet Genomics 18:895-902
Chung, Cecilia P; Oeser, Annette; Raggi, Paolo et al. (2008) Lipoprotein subclasses and particle size determined by nuclear magnetic resonance spectroscopy in systemic lupus erythematosus. Clin Rheumatol 27:1227-33
Chung, Cecilia P; Oeser, Annette; Solus, Joseph F et al. (2008) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196:756-63
Schwarz, Ute I; Ritchie, Marylyn D; Bradford, Yuki et al. (2008) Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 358:999-1008
Chung, Cecilia P; Solus, Joseph F; Oeser, Annette et al. (2008) N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflammation, augmentation index, and coronary calcification. J Rheumatol 35:1314-9
Chung, Cecilia P; Oeser, Annette; Solus, Joseph F et al. (2008) Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum 58:2105-12
Avalos, I; Chung, C P; Oeser, A et al. (2007) Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus 16:195-200
Chung, Cecilia P; Avalos, Ingrid; Oeser, Annette et al. (2007) High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 66:208-14

Showing the most recent 10 out of 59 publications